Tag Archives: Arthritis drug fails COVID-19 study

Regeneron Pharmaceuticals and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a US study testing it in the most critically ill COVID-19 patients. Previous trial results had shown that the drug did not help patients with less severe COVID-19, the disease caused by the novel coronavirus, and shares of Regeneron fell about …

Read More »